Potential Benefits
Both LIRA and SEMA have demonstrated nephroprotective effects in individuals with diabetes, suggesting that systolic blood pressure and HbA1c levelsrather than weightare the most influential mediators, although other factors also play a role (Fig
10.1002/eji.201948448 44 VenketaramanV.DayaramY
3841 Furthermore, a systematic review and meta-analysis of 14 clinical trials showed that intensive glucose control had no significant effect on all-cause mortality in patients with type 2 diabetes compared with conventional control
Acetyl L-carnitine (ALC), de geacetyleerde vorm van het lichaamseigen carnitine, 1000 mg per dagdosering
"There are a number of others trying to break into [the market] both small and large, but when I step back, I do think that Amgen has a real shot at being disruptive and challenging Eli Lilly and Novo," William Blair & Company analyst Matt Phipps told CNBC